<br />
<b>Deprecated</b>: urlencode(): Passing null to parameter #1 ($string) of type string is deprecated in <b>/var/www/html/diabetesnews.com/wp-content/themes/dn_default/single.php</b> on line <b>22</b><br />
)
Invokana, a member of the new class of drugs known as sodium glucose co-transporter 2 (SGLT2) inhibitors, was approved in the USA as a single agent in March 2013.
DiabetesInControl – FDA Approves J&J’s Invokamet Combo (SGLT-2 + Metformin)
Posted in Drugs